CG
BPMC

Carmignac Gestion’s Blueprint Medicines BPMC Stock Holding History

Carmignac Gestion’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-54,676
Closed -$7.01M – 136
2025
Q2 		$7.01M Buy
+54,676
New +$5.68M 0.11% 67

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Carmignac Gestion's BPMC Position: Q3 2025 in Review

Carmignac Gestion sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 54,676 shares — an estimated $7.01M sold.

Carmignac Gestion first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $7.01M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Carmignac Gestion reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Carmignac Gestion sold 54,676 Blueprint Medicines shares in Q3 2025, an estimated $7.01M.
  • Carmignac Gestion first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
  • Carmignac Gestion's Blueprint Medicines position peaked at $7.01M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Carmignac Gestion's 13F filing for Q3 2025, filed 13 Nov 2025.